Cardiovascular diseases Trials in Homburg, Germany
Conditions / Cardiovascular diseases / Homburg, Germany
Clinical trials for Cardiovascular diseases investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04311086 | SPYRAL DYSTAL Renal Denervation Global Clinical Study | COMPLETED | NA |
| NCT02439775 | SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System | COMPLETED | NA |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT04271280 | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events | COMPLETED | — |
| NCT02439749 | SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study | COMPLETED | NA |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT07115953 | Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension | RECRUITING | NA |
| NCT03614260 | The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension | ACTIVE_NOT_RECRUITING | NA |
| NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING | — |